American Healthcare REIT, Inc (AHR) PT Raised to $17 at Truist Securities

Truist Securities analyst Michael Lewis raised the price target on American Healthcare REIT, Inc (NYSE: AHR) to $17.00 (from $16.00) while maintaining a Buy rating.

The analyst commented: "Our 2024 & ’25 FFO estimates are unchanged, and we are increasing our price target to $17 from $16, which implies a 24% total return. In the near term, we expect AHR to walk a fine line as it balances slightly above-target financial leverage with attractive investment opportunities including the Trilogy purchase option. We think the company’s potential growth profile is strong relative to the stock’s valuation (low PEG ratios), and the stock could benefit from acquiring the rest of Trilogy and improving dividend coverage next year."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• Phillips 66, Marathon Merger Talks Collapsed - Semafor